{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:07:28Z","timestamp":1770840448079,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,22]]},"DOI":"10.7759\/cureus.52752","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T04:21:06Z","timestamp":1705983666000},"source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the Predictive Power: Placenta Growth Factor and Pregnancy-Associated Plasma Protein A in Pre-eclampsia"],"prefix":"10.7759","author":[{"given":"Aditi","family":"Singh Thakur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surekha","family":"Tayade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drashti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishwarya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitish","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review","volume":"76","author":"Ives CW","year":"2020","unstructured":"Ives CW, Sinkey R, Rajapreyar I, Tita AT, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 76:1690-702. 10.1016\/j.jacc.2020.08.014","journal-title":"J Am Coll Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps EA","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019, 15:275-89. 10.1038\/s41581-019-0119-6","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2017.60.2.154","article-title":"Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study","volume":"60","author":"Sung KU","year":"2017","unstructured":"Sung KU, Roh JA, Eoh KJ, Kim EH. Maternal serum placental growth factor and pregnancy-associated plasma protein A measured in the first trimester as parameters of subsequent pre-eclampsia and small-for-gestational-age infants: a prospective observational study. Obstet Gynecol Sci. 2017, 60:154-62. 10.5468\/ogs.2017.60.2.154","journal-title":"Obstet Gynecol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713252","article-title":"From biomarkers to the molecular mechanism of preeclampsia-a comprehensive literature review","volume":"24","author":"Rybak-Krzyszkowska M","year":"2023","unstructured":"Rybak-Krzyszkowska M, Staniczek J, Kondracka A, et al.. From biomarkers to the molecular mechanism of preeclampsia-a comprehensive literature review. Int J Mol Sci. 2023, 24:13252. 10.3390\/ijms241713252","journal-title":"Int J Mol Sci"},{"key":"ref5","unstructured":"Preeclampsia. clinical features and diagnosis. (2023). Accessed: January 3, 2024: https:\/\/www.uptodate.com\/contents\/preeclampsia-clinical-features-and-diagnosis\/print."},{"key":"ref6","article-title":"Eclampsia","author":"Magley M","year":"2023","unstructured":"Magley M, Hinson MR. Eclampsia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref7","article-title":"Preeclampsia","author":"Karrar SA","year":"2023","unstructured":"Karrar SA, Hong PL. Preeclampsia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref8","unstructured":"Preeclampsia. practice essentials, overview, pathophysiology. (2023). Accessed: October 29, 2023: https:\/\/emedicine.medscape.com\/article\/1476919-overview?form=fpf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31143","article-title":"Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors","volume":"14","author":"Khan B","year":"2022","unstructured":"Khan B, Allah Yar R, Khakwani AK, Karim S, Arslan Ali H. Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors. Cureus. 2022, 14:e31143. 10.7759\/cureus.31143","journal-title":"Cureus"},{"key":"ref10","unstructured":"Who Is at Risk of Preeclampsia?. (2022). Accessed. January 3, 2024: https:\/\/www.nichd.nih.gov\/health\/topics\/preeclampsia\/conditioninfo\/risk."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00839-w","article-title":"Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh","volume":"11","author":"Mou AD","year":"2021","unstructured":"Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, Ali N. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021, 11:21339. 10.1038\/s41598-021-00839-w","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.10.006","article-title":"Pre-eclampsia has an adverse impact on maternal and fetal health","volume":"165","author":"Lin S","year":"2015","unstructured":"Lin S, Leonard D, Co MA, et al.. Pre-eclampsia has an adverse impact on maternal and fetal health. Transl Res. 2015, 165:449-63. 10.1016\/j.trsl.2014.10.006","journal-title":"Transl Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00071.2020","article-title":"Preeclampsia beyond pregnancy: long-term consequences for mother and child","volume":"318","author":"Turbeville HR","year":"2020","unstructured":"Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020, 318:F1315-26. 10.1152\/ajprenal.00071.2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4863.154669","article-title":"Maternal and fetal outcome in pre-eclampsia in a secondary care hospital in South India","volume":"4","author":"Aabidha PM","year":"2015","unstructured":"Aabidha PM, Cherian AG, Paul E, Helan J. Maternal and fetal outcome in pre-eclampsia in a secondary care hospital in South India. J Family Med Prim Care. 2015, 4:257-60. 10.4103\/2249-4863.154669","journal-title":"J Family Med Prim Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2023.100193","article-title":"Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy-associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1-placental growth factor ratio in the early second trimester","volume":"3","author":"Huang T","year":"2023","unstructured":"Huang T, Rashid S, Priston M, et al.. Prenatal screening for preeclampsia: the roles of placental growth factor and pregnancy-associated plasma protein A in the first trimester and placental growth factor and soluble fms-like tyrosine kinase 1-placental growth factor ratio in the early second trimester. AJOG Glob Rep. 2023, 3:100193. 10.1016\/j.xagr.2023.100193","journal-title":"AJOG Glob Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M313237200","article-title":"The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1","volume":"279","author":"Christinger HW","year":"2004","unstructured":"Christinger HW, Fuh G, de Vos AM, Wiesmann C. The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. J Biol Chem. 2004, 279:10382-8. 10.1074\/jbc.M313237200","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1050-1738(02)00168-8","article-title":"Structure and function of placental growth factor","volume":"12","author":"De Falco S","year":"2002","unstructured":"De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor. Trends Cardiovasc Med. 2002, 12:241-6. 10.1016\/S1050-1738(02)00168-8","journal-title":"Trends Cardiovasc Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2012.44.1.025","article-title":"The discovery of placenta growth factor and its biological activity","volume":"44","author":"De Falco S","year":"2012","unstructured":"De Falco S. The discovery of placenta growth factor and its biological activity. Exp Mol Med. 2012, 44:1-9. 10.3858\/emm.2012.44.1.025","journal-title":"Exp Mol Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2017.61","article-title":"Placental growth factor and pre-eclampsia","volume":"31","author":"Chau K","year":"2017","unstructured":"Chau K, Hennessy A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens. 2017, 31:782-6. 10.1038\/jhh.2017.61","journal-title":"J Hum Hypertens"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1933719110389337","article-title":"Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway","volume":"18","author":"Depoix C","year":"2011","unstructured":"Depoix C, Tee MK, Taylor RN. Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway. Reprod Sci. 2011, 18:219-28. 10.1177\/1933719110389337","journal-title":"Reprod Sci"},{"key":"ref21","article-title":"Expression of placental growth factor mRNA in preeclampsia","volume":"15","author":"Nikuei P","year":"2017","unstructured":"Nikuei P, Rajaei M, Malekzadeh K, et al.. Expression of placental growth factor mRNA in preeclampsia. Int J Reprod Biomed. 2017, 15:169-74.","journal-title":"Int J Reprod Biomed"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2016-021","article-title":"Physiological changes in pregnancy","volume":"27","author":"Soma-Pillay P","year":"2016","unstructured":"Soma-Pillay P, Nelson-Piercy C, Tolppanen H, Mebazaa A. Physiological changes in pregnancy. Cardiovasc J Afr. 2016, 27:89-94. 10.5830\/CVJA-2016-021","journal-title":"Cardiovasc J Afr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine MM","year":"2014","unstructured":"Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014, 5:65. 10.3389\/fphar.2014.00065","journal-title":"Front Pharmacol"},{"key":"ref24","unstructured":"Physiological Changes in Pregnancy. (2024). Accessed. January 3, 2024: https:\/\/www.physio-pedia.com\/Physiological_Changes_in_Pregnancy."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2016-009","article-title":"Pre-eclampsia: its pathogenesis and pathophysiolgy","volume":"27","author":"Gathiram P","year":"2016","unstructured":"Gathiram P, Moodley J. Pre-eclampsia: its pathogenesis and pathophysiolgy. Cardiovasc J Afr. 2016, 27:71-8. 10.5830\/CVJA-2016-009","journal-title":"Cardiovasc J Afr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.112.099861","article-title":"The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms","volume":"87","author":"Laresgoiti-Servitje E","year":"2012","unstructured":"Laresgoiti-Servitje E, Gomez-Lopez N. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod. 2012, 87:36. 10.1095\/biolreprod.112.099861","journal-title":"Biol Reprod"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13360","article-title":"Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis","volume":"74","author":"Agrawal S","year":"2019","unstructured":"Agrawal S, Shinar S, Cerdeira AS, Redman C, Vatish M. Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis. Hypertension. 2019, 74:1124-35. 10.1161\/HYPERTENSIONAHA.119.13360","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a023473","article-title":"Molecular mechanisms of preeclampsia","volume":"5","author":"Hod T","year":"2015","unstructured":"Hod T, Cerdeira AS, Karumanchi SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med. 2015, 5:023473. 10.1101\/cshperspect.a023473","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2007.04.009","article-title":"Molecular mechanisms of preeclampsia","volume":"75","author":"Mutter WP","year":"2008","unstructured":"Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008, 75:1-8. 10.1016\/j.mvr.2007.04.009","journal-title":"Microvasc Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2016.152","article-title":"Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction","volume":"40","author":"Tomimatsu T","year":"2017","unstructured":"Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017, 40:305-10. 10.1038\/hr.2016.152","journal-title":"Hypertens Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45080391","article-title":"Pre-eclampsia: from etiology and molecular mechanisms to clinical tools-a review of the literature","volume":"45","author":"Tabacco S","year":"2023","unstructured":"Tabacco S, Ambrosii S, Polsinelli V, et al.. Pre-eclampsia: from etiology and molecular mechanisms to clinical tools-a review of the literature. Curr Issues Mol Biol. 2023, 45:6202-15. 10.3390\/cimb45080391","journal-title":"Curr Issues Mol Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00973","article-title":"Preeclampsia: novel mechanisms and potential therapeutic approaches","volume":"9","author":"Armaly Z","year":"2018","unstructured":"Armaly Z, Jadaon JE, Jabbour A, Abassi ZA. Preeclampsia: novel mechanisms and potential therapeutic approaches. Front Physiol. 2018, 9:973. 10.3389\/fphys.2018.00973","journal-title":"Front Physiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883404","article-title":"Inflammation in preeclampsia: genetic biomarkers, mechanisms, and therapeutic strategies","volume":"13","author":"Wang Y","year":"2022","unstructured":"Wang Y, Li B, Zhao Y. Inflammation in preeclampsia: genetic biomarkers, mechanisms, and therapeutic strategies. Front Immunol. 2022, 13:883404. 10.3389\/fimmu.2022.883404","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia","volume":"130","author":"Harmon AC","year":"2016","unstructured":"Harmon AC, Cornelius DC, Amaral LM, Faulkner JL, Cunningham MW Jr, Wallace K, LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin Sci (Lond). 2016, 130:409-19. 10.1042\/CS20150702","journal-title":"Clin Sci (Lond)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1130116","article-title":"Setting a stage: inflammation during preeclampsia and postpartum","volume":"14","author":"Herrock O","year":"2023","unstructured":"Herrock O, Deer E, LaMarca B. Setting a stage: inflammation during preeclampsia and postpartum. Front Physiol. 2023, 14:1130116. 10.3389\/fphys.2023.1130116","journal-title":"Front Physiol"},{"key":"ref36","article-title":"Chapter 26 - oxidative stress in preeclampsia","author":"Agarwal A","year":"2015","unstructured":"Agarwal A, Tvrda E, Mulgund A. Chapter 26 - oxidative stress in preeclampsia. Handbook of fertility. Watson RR (ed): Academic Press, San Diego; 2015. 283-290."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.12.005","article-title":"Oxidative stress: normal pregnancy versus preeclampsia","volume":"1866","author":"Chiarello DI","year":"2020","unstructured":"Chiarello DI, Abad C, Rojas D, et al.. Oxidative stress: normal pregnancy versus preeclampsia. Biochim Biophys Acta Mol Basis Dis. 2020, 1866:165354. 10.1016\/j.bbadis.2018.12.005","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000141085.98320.01","article-title":"Oxidative stress and preeclampsia: rationale for antioxidant clinical trials","volume":"44","author":"Raijmakers MT","year":"2004","unstructured":"Raijmakers MT, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004, 44:374-80. 10.1161\/01.HYP.0000141085.98320.01","journal-title":"Hypertension"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5581570","article-title":"The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus)","volume":"2021","author":"Phoswa WN","year":"2021","unstructured":"Phoswa WN, Khaliq OP. The role of oxidative stress in hypertensive disorders of pregnancy (preeclampsia, gestational hypertension) and metabolic disorder of pregnancy (gestational diabetes mellitus). Oxid Med Cell Longev. 2021, 2021:5581570. 10.1155\/2021\/5581570","journal-title":"Oxid Med Cell Longev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051496","article-title":"Oxidative stress in preeclampsia and placental diseases","volume":"19","author":"Aouache R","year":"2018","unstructured":"Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci. 2018, 19:1496. 10.3390\/ijms19051496","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59020398","article-title":"Placental growth factor and pregnancy-associated plasma protein-A as potential early predictors of gestational diabetes mellitus","volume":"59","author":"Yanachkova V","year":"2023","unstructured":"Yanachkova V, Staynova R, Stankova T, Kamenov Z. Placental growth factor and pregnancy-associated plasma protein-A as potential early predictors of gestational diabetes mellitus. Medicina (Kaunas). 2023, 59:398. 10.3390\/medicina59020398","journal-title":"Medicina (Kaunas)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159592","article-title":"Pregnancy associated plasma protein-A and placental growth factor in a sub-Saharan African population: a nested cross-sectional study","volume":"11","author":"Browne JL","year":"2016","unstructured":"Browne JL, Klipstein-Grobusch K, Koster MP, et al.. Pregnancy associated plasma protein-A and placental growth factor in a sub-Saharan African population: a nested cross-sectional study. PLoS One. 2016, 11:0159592. 10.1371\/journal.pone.0159592","journal-title":"PLoS One"},{"key":"ref43","article-title":"Screening for preeclampsia: recommendation statement","volume":"97","year":"2018","unstructured":"Screening for preeclampsia. recommendation statement. Am Fam Physician. 2018, 97:","journal-title":"Am Fam Physician"},{"key":"ref44","article-title":"Screening for preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force","author":"Henderson JT","year":"2017","unstructured":"Henderson JT, Thompson JH, Burda BU, Cantor A, Beil T, Whitlock EP. Screening for preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality (US), Rockville (MD); 2017."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.3439","article-title":"Screening for preeclampsia: US Preventive Services Task Force recommendation statement","volume":"317","author":"Bibbins-Domingo K","year":"2017","unstructured":"Bibbins-Domingo K, Grossman DC, Curry SJ, et al.. Screening for preeclampsia: US Preventive Services Task Force recommendation statement. JAMA. 2017, 317:1661-7. 10.1001\/jama.2017.3439","journal-title":"JAMA"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.18315","article-title":"Preeclampsia screening: evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Henderson JT","year":"2017","unstructured":"Henderson JT, Thompson JH, Burda BU, Cantor A. Preeclampsia screening: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017, 317:1668-83. 10.1001\/jama.2016.18315","journal-title":"JAMA"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:plgf ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler H","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, et al.. Predictive value of the sFlt-1:plgf ratio in women with suspected preeclampsia. N Engl J Med. 2016, 374:13-22. 10.1056\/NEJMoa1414838","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald TM","year":"2022","unstructured":"MacDonald TM, Walker SP, Hannan NJ, Tong S, Kaitu'u-Lino TJ. Clinical tools and biomarkers to predict preeclampsia. EBioMedicine. 2022, 75:103780. 10.1016\/j.ebiom.2021.103780","journal-title":"EBioMedicine"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/uog.24918","article-title":"Impact of replacing or adding pregnancy-associated plasma protein-A at 11-13\u2009weeks on screening for preterm pre-eclampsia","volume":"60","author":"Wah YM","year":"2022","unstructured":"Wah YM, Sahota DS, Chaemsaithong P, et al.. Impact of replacing or adding pregnancy-associated plasma protein-A at 11-13\u2009weeks on screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2022, 60:200-6. 10.1002\/uog.24918","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4137\/CMRH.S21865","article-title":"Combination of PAPPA, fhCG\u03b2, AFP, PlGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia","volume":"9","author":"Yliniemi A","year":"2015","unstructured":"Yliniemi A, Makikallio K, Korpimaki T, Kouru H, Marttala J, Ryynanen M. Combination of PAPPA, fhCG\u03b2, AFP, PlGF, sTNFR1, and maternal characteristics in prediction of early-onset preeclampsia. Clin Med Insights Reprod Health. 2015, 9:13-20. 10.4137\/CMRH.S21865","journal-title":"Clin Med Insights Reprod Health"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17096","article-title":"Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: adjusting for the effect of aspirin treatment","volume":"129","author":"Wright D","year":"2022","unstructured":"Wright D, Tan MY, O'Gorman N, Syngelaki A, Nicolaides KH. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: adjusting for the effect of aspirin treatment. BJOG. 2022, 129:1308-17. 10.1111\/1471-0528.17096","journal-title":"BJOG"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-S3-S6","article-title":"Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths","volume":"11 Suppl 3","author":"Jabeen M","year":"2011","unstructured":"Jabeen M, Yakoob MY, Imdad A, Bhutta ZA. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BMC Public Health. 2011, 11 Suppl 3:S6. 10.1186\/1471-2458-11-S3-S6","journal-title":"BMC Public Health"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0757-7","article-title":"Pathophysiology and current clinical management of preeclampsia","volume":"19","author":"Amaral LM","year":"2017","unstructured":"Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and current clinical management of preeclampsia. Curr Hypertens Rep. 2017, 19:61. 10.1007\/s11906-017-0757-7","journal-title":"Curr Hypertens Rep"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20042994","article-title":"Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition","volume":"20","author":"Chang KJ","year":"2023","unstructured":"Chang KJ, Seow KM, Chen KH. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Public Health. 2023, 20:2994. 10.3390\/ijerph20042994","journal-title":"Int J Environ Res Public Health"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.12703\/b\/9-10","article-title":"Recent advances in the diagnosis and management of pre-eclampsia","volume":"9","author":"Hurrell A","year":"2020","unstructured":"Hurrell A, Duhig K, Vandermolen B, Shennan AH. Recent advances in the diagnosis and management of pre-eclampsia. Fac Rev. 2020, 9:10. 10.12703\/b\/9-10","journal-title":"Fac Rev"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.05.004","article-title":"Is preeclampsia an autoimmune disease?","volume":"133","author":"Xia Y","year":"2009","unstructured":"Xia Y, Kellems RE. Is preeclampsia an autoimmune disease?. Clin Immunol. 2009, 133:1-12. 10.1016\/j.clim.2009.05.004","journal-title":"Clin Immunol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8101625","article-title":"Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring","volume":"8","author":"Fox R","year":"2019","unstructured":"Fox R, Kitt J, Leeson P, Aye CY, Lewandowski AJ. Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019, 8:1625. 10.3390\/jcm8101625","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/222006-unraveling-the-predictive-power-placenta-growth-factor-and-pregnancy-associated-plasma-protein-a-in-pre-eclampsia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:50Z","timestamp":1707509630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/222006-unraveling-the-predictive-power-placenta-growth-factor-and-pregnancy-associated-plasma-protein-a-in-pre-eclampsia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":57,"URL":"https:\/\/doi.org\/10.7759\/cureus.52752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}